The World Health Organization (WHO) has officially classified Omicron (SARS-CoV-2) as a Variant of Concern (VOC). As of this writing, there have been no cases of the new variant identified in the U.S., but experts warn it's only a matter of time. There's a lot to be learned about how Omicron spreads, how symptoms present and its response to vaccines. Researchers around the globe are working to get a better understanding of the variant. Let’s look at what is currently known about the virus and the expected impact on public health. Variant of Concern (VOC) WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) found Omicron meets the definition of a Variant of Concern (VOC) after an extensive comparative analysis of available data. TAG-VE, an independent group of experts, found Omicron to be associated with one or more of the changes that could impact global health: Increase in how easily it spreads or detrimental change in COVID-19 epidemiology; OR Increase in virulence (severity) or change in clinical presentation; OR Decrease in effectiveness of public health and social measures or available diagnostics, vaccines, or therapeutics. You can learn more about the VOCs here. Omicron Timeline Here is a snapshot of Omicron’s timeline: November 9, 2021 The first known infection of Omicron, then known as B.1.1.529, was confirmed from a specimen collected in South Africa. November 24, 2021 South Africa announced the detection of a new variant after studying its DNA sequence. November 26, 2021 WHO designated Omicron a VOC. The U.S. issued a travel ban for non-U.S. citizens travelers from South Africa, Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique and Malawi. November 27, 2021 A recorded 115 cases have been identified, primarily from Botswana and South Africa. However, cases were also reported in Hong Kong, Belgium, Israel, Germany, Netherlands and the United Kingdom Transmission According to WHO, it is not yet known if Omicron spreads more easily from person to person when compared to Delta and other variants. Epidemiologists are conducting studies to determine if the rising number of people testing positive in certain areas of South Africa are due to Omicron or other factors. Severity of Omicron Infection It’s not yet known if an Omicron infection will present with more severe symptoms when compared to other COVID-19 variants. It was initially reported that Omicron infections were associated with mild symptoms. However, early infections were among college students and people who are younger tend to have milder illness. It will take days to weeks for experts to understand Omicron’s level of severity. Vaccine Effectiveness WHO has not yet determined if Omicron will have an impact on our current COVID-19 vaccines, but is working with other partners to find the answer. WHO emphasizes vaccines remain effective against severe COVID-19 disease and death. Test Effectiveness COVID-19 PCR tests have been able to detect Omicron infection. Studies are ongoing to determine any impact on rapid antigen testing. However, the FDA reported in a recent media statement that rapid antigen tests used in the U.S. show a “low likelihood of being impacted and continue to work”. Treatments Corticosteroids and IL6 Receptor Blockers remain effective treatments for patients with severe COVID-19. However, further assessment is needed to determine if other treatments are still effective in treating the Omicron variant. Virus Protection The CDC recommends prevention strategies that have proved effective in the prevention of COVID-19 to protect yourself and others from the virus and the Omicron variant. Wear a mask in public indoor settings with substantial to high community transmission. Wash your hands frequently and practice good hand hygiene. Continue to practice social distancing. If age 5 or older, get fully vaccinated and a vaccine booster dose for those who are eligible Returning From Another Country The CDC recommends the following for travelers returning from South Africa, Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique and Malawi Test for COVID-19 within 3-5 days after arrival Quarantine for 7 days Isolate and test if experiencing COVID-19 symptoms Let’s Hear From You What (if anything) is your employer doing differently in response to the Omicron threat? References / Resources World Health Organization - Tracking SARS-CoV-2 Variants World Health Organization - Update on Omicron Coronavirus (COVID-19) Update: FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters 3 Down Vote Up Vote × About J.Adderton, BSN, MSN (Columnist) Experienced nurse specializing in clinical leadership, staff development and nursing education. 121 Articles 502 Posts Share this post Share on other sites